Cite Filings / INO / 0000919574-26-002915
Feed Companies Filings Check
Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

INOVIO PHARMACEUTICALS, INC. · Filed 2026-05-13 · Acc 0000919574-26-002915

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-05-18 4 Chief Scientific Officer gave up 1,712 shares (to pay taxes)
  • 2026-05-18 4 CFO gave up 2,571 shares (to pay taxes)
  • 2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-05-13 8-K Results of operations
  • 2026-05-13 10-Q Quarterly Report
  • 2026-05-13 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-05-06 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · TANG CAPITAL MANAGEMENT, LLC 9.99%
  2. 2026-11-16 SCHEDULE 13G/A · Alyeska Investment Group, L.P. 3.32%
  3. 2026-11-16 SCHEDULE 13G · ADAR1 Capital Management, LLC 7.4%
  4. 2026-11-16 SCHEDULE 13G/A · Highbridge Capital Management, LLC 9.9%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…